Drugs / G-CSF
last change Sep 2013 re-read 2 minutes ago

G-CSF

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00733824 Background Nov 2008 → Sep 2012 Hodgkins lymphoma, non-Hodgkin lymphoma Washington University School of Medicine Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as G-CSF ClinicalTrials.gov intervention name — accepted as the source's own label NCT00733824
Route Subcutaneous “10 µg/kg SC G-CSF Day -4 thru Day -1” NCT00733824